AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

INNOVATE Corp.

$7.24 +$2.04 (+39.23%)
NYSE · 14 Sep 2026 20:00 UTC
Previous Close
$7.16
Day Range
$7$7.34
Year Range
$3.75$21.3
Market Cap
98.77M
AVG Volume
297.77K
Trailing/Forward PE
-3.93/0.2
PEG ratio
0.01
Dividend Yield
10.77%
Next Earnings Date
2026-11-12
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
0500M1B1.5B2B2016201720182019202020212022202320242025
VATE Revenue (USD) by year
PeriodRevenue (USD)
20251.25B
20241.11B
20231.42B
20221.64B
20211.21B
2020329.6M
20191.98B
20181.98B
20171.63B
20161.56B
Net Income (USD)
-300M-200M-100M0100M200M2016201720182019202020212022202320242025
VATE Net Income (USD) by year
PeriodNet Income (USD)
2025-60.6M
2024-34.6M
2023-35.2M
2022-35.9M
2021-227.5M
2020-92M
2019-17.9M
2018138.9M
2017-49.7M
2016-105.4M
Operating Income (USD)
-75M-50M-25M025M50M2016201720182019202020212022202320242025
VATE Operating Income (USD) by year
PeriodOperating Income (USD)
202531.6M
202440M
202326.5M
202213.4M
2021-10.6M
2020-18.7M
201929.1M
2018-55.83M
2017-1.13M
2016-2.26M
EBITDA (USD)
020M40M60M80M2016201720182019202020212022202320242025
VATE EBITDA (USD) by year
PeriodEBITDA (USD)
202557.9M
202474M
202374.5M
202260.8M
202116.2M
202066.9M
201967M
201876.05M
201751.95M
201624.27M
Cash Flows (USD)
-100M0100M200M300M400M2016201720182019202020212022202320242025
VATE Cash Flows (USD) by year
PeriodCash Flows (USD)
2025120.5M
2024-9.9M
20238.1M
2022-30.2M
20212.9M
202023.3M
201974.9M
2018301.7M
2017-25.78M
201650.1M
EPS (USD)
-40-20020402016201720182019202020212022202320242025
VATE EPS (USD) by year
PeriodEPS (USD)
2025-4.85
2024-3.72
2023-4.66
2022-5.26
2021-10.43
2020-9.39
2019-5.31
201829.87
2017-11.64
2016-26.95
Expenses (USD)
0100M200M300MR&DSG&ACapex2016201720182019202020212022202320242025
VATE Expenses (USD) by year
PeriodExpenses (USD)
2025140.4M
2024102.3M
202318.4M
202220.7M
2021145M
2020162.5M
2019149.2M
2018258.14M
2017214.81M
2016183.26M
Cash & Debt (USD)
01B2B3B4BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
VATE Cash & Debt (USD) by year
PeriodCash & Debt (USD)
2025112.1M
202448.8M
202380.8M
202280.4M
202145.5M
202045.3M
2019193.7M
20183.72B
20171.44B
20161.39B
Debt ratios
-20-15-10-50520182019202020212022202320242025
VATE Debt ratios by year
PeriodDebt ratios
20252.27
20242.97
20233.16
20223.34
20212.83
20202.13
20192.65
2018-16.15
Margins
0%10%20%30%40%2016201720182019202020212022202320242025
VATE Margins by year
PeriodMargins
202514.98%
202418.86%
202315.18%
202213.52%
202115.24%
202038.02%
201911.29%
20189.82%
201713%
201611.6%
Return on Capital
-1000%0%1000%2000%3000%4000%2016201720182019202020212022202320242025
VATE Return on Capital by year
PeriodReturn on Capital
202528.15%
202421.65%
202323.05%
2022121.28%
20213297.1%
2020-14.94%
2019-3.85%
201868.86%
2017-26.19%
2016-150.64%
Shares Outstanding
05M10M15M2016201720182019202020212022202320242025
VATE Shares Outstanding by year
PeriodShares Outstanding
202513.34M
202413.08M
20237.85M
20227.76M
20217.73M
20206.12M
20194.3M
20186.62M
20176.62M
20166.62M
Dividends (USD)
0255075100201220132026
VATE Dividends (USD) by year
PeriodDividends (USD)
20260.78
201385
201240
Employee Count
01K2K3K4K2016201720182019202020212022202320242025
VATE Employee Count by year
PeriodEmployee Count
20253.59K
20243.13K
20233.95K
20223.56K
20213.79K
20202.53K
20192.98K
20183.36K
20172.67K
20162.09K
Book Value Per Share (USD)
-500501001502016201720182019202020212022202320242025
VATE Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2025-16.14
2024-12.22
2023-19.45
2022-3.81
2021-0.89
2020100.64
2019108.22
201830.45
201728.64
201610.56
Total Assets (USD)
02B4B6B8B2016201720182019202020212022202320242025
VATE Total Assets (USD) by year
PeriodTotal Assets (USD)
2025950.1M
2024891.1M
20231.04B
20221.15B
20211.08B
20206.72B
20196.96B
20186.5B
20173.22B
20162.84B
PE Ratio
0100200300400med 1.41Sep 18Dec 18Mar 19May 19Aug 19May 21Jul 21
VATE PE Ratio by year
PeriodPE Ratio
Jul 2176.17
Jul 2172.65
Jul 2174.1
Jul 2180.1
Jul 2182.38
Jun 2187.14
Jun 2181.55
Jun 2189
Jun 2189.21
May 2182.8
May 2181.14
May 2182.8
May 2177.21
Nov 191.07
Oct 191.01
Oct 190.96
Oct 190.91
Oct 190.96
Sep 191.09
Sep 191.07
Sep 191.04
Sep 190.92
Aug 190.89
Aug 190.87
Aug 190.95
Aug 191.04
Aug 190.68
Jul 190.63
Jul 190.64
Jul 190.71
Jul 190.71
Jun 190.75
Jun 190.72
Jun 190.77
Jun 190.74
May 190.73
May 190.85
May 190.9
May 190.88
May 191.13
Apr 191.07
Apr 191.14
Apr 191.11
Apr 191.19
Mar 191.17
Mar 191.24
Mar 191.25
Mar 191.39
Mar 191.46
Feb 191.55
Feb 191.52
Feb 191.45
Feb 191.61
Jan 191.61
Jan 191.61
Jan 191.49
Jan 191.33
Dec 181.2
Dec 181.17
Dec 181.47
Dec 181.39
Nov 181.45
Nov 181.43
Nov 181.48
Nov 182.27
Nov 18322.37
Oct 18319.93
Oct 18326.04
Oct 18346.23
Oct 18347.45
Sep 18374.37
Sep 18362.75
Sep 18368.86
Sep 18374.37
Aug 18383.54
Aug 18389.66
Aug 18382.93
Aug 18360.3
Free Cash Flow Yield
-100%0%100%200%med 29.64%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VATE Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26146.64%
Sep 26148.28%
Sep 26142.7%
Aug 26139.88%
Aug 26135.08%
Aug 26133.38%
Aug 2687.67%
Jul 26161.77%
Jul 26157.51%
Jul 26145.47%
Jul 26132.29%
Jul 2688.7%
Jun 2668.03%
Jun 2665.48%
Jun 2678.56%
Jun 2669.21%
May 2686.25%
May 26100.28%
May 26123.23%
May 2677%
May 2676.55%
Apr 2669.48%
Apr 2684.5%
Apr 26105.52%
Apr 26116.25%
Mar 26196.79%
Mar 26115.15%
Mar 26109.15%
Mar 2696.36%
Feb 2686.91%
Feb 2690.85%
Feb 2691.57%
Feb 2686.75%
Jan 2682.4%
Jan 2682.7%
Jan 2682.25%
Jan 2691.03%
Jan 2688.58%
Dec 2593.62%
Dec 2588.92%
Dec 25103.74%
Dec 2593.62%
Nov 2589.09%
Nov 2588.24%
Nov 2589.44%
Nov 2524.37%
Oct 2525.54%
Oct 2524.68%
Oct 2530.56%
Oct 2531.39%
Oct 2529.77%
Sep 2528.9%
Sep 2527.47%
Sep 2527.41%
Sep 2524.55%
Aug 2525.59%
Aug 2528.37%
Aug 2529.52%
Aug 2526.88%
Aug 253.33%
Jul 253.02%
Jul 253.22%
Jul 253.16%
Jul 253.22%
Jun 253.27%
Jun 253.29%
Jun 253.25%
Jun 253.05%
May 253.03%
May 252.77%
May 252.92%
May 252.47%
May 25-11.2%
Apr 25-11.42%
Apr 25-13.05%
Apr 25-12.11%
Apr 25-13.09%
Mar 2511.91%
Mar 2511.27%
Mar 2512.44%
Mar 2512.09%
Feb 2510.66%
Feb 258.99%
Feb 257.6%
Feb 258.18%
Jan 258.36%
Jan 259.18%
Jan 2519.02%
Jan 2519.47%
Jan 2517.77%
Dec 2418.23%
Dec 2418.51%
Dec 2417.67%
Dec 2415.57%
Nov 2416.04%
Nov 2416.22%
Nov 2424.29%
Nov 2421.74%
Nov 24122.14%
Oct 24115.14%
Price to Sales
00.050.10.150.20.25med 0.07Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VATE Price to Sales by year
PeriodPrice to Sales
Sep 260.06
Sep 260.06
Sep 260.07
Aug 260.07
Aug 260.07
Aug 260.07
Aug 260.11
Jul 260.08
Jul 260.08
Jul 260.09
Jul 260.1
Jul 260.15
Jun 260.19
Jun 260.2
Jun 260.17
Jun 260.19
May 260.15
May 260.13
May 260.11
May 260.13
May 260.13
Apr 260.14
Apr 260.11
Apr 260.09
Apr 260.08
Mar 260.05
Mar 260.05
Mar 260.05
Mar 260.06
Feb 260.06
Feb 260.06
Feb 260.06
Feb 260.06
Jan 260.07
Jan 260.07
Jan 260.07
Jan 260.06
Jan 260.06
Dec 250.06
Dec 250.06
Dec 250.05
Dec 250.06
Nov 250.06
Nov 250.06
Nov 250.06
Nov 250.08
Oct 250.07
Oct 250.07
Oct 250.06
Oct 250.06
Oct 250.06
Sep 250.06
Sep 250.07
Sep 250.07
Sep 250.07
Aug 250.07
Aug 250.06
Aug 250.06
Aug 250.07
Aug 250.06
Jul 250.07
Jul 250.07
Jul 250.07
Jul 250.07
Jun 250.07
Jun 250.07
Jun 250.07
Jun 250.07
May 250.07
May 250.08
May 250.07
May 250.09
May 250.08
Apr 250.08
Apr 250.07
Apr 250.07
Apr 250.07
Mar 250.09
Mar 250.09
Mar 250.08
Mar 250.08
Feb 250.1
Feb 250.11
Feb 250.13
Feb 250.13
Jan 250.12
Jan 250.11
Jan 250.05
Jan 250.05
Jan 250.06
Dec 240.06
Dec 240.06
Dec 240.06
Dec 240.07
Nov 240.06
Nov 240.06
Nov 240.04
Nov 240.05
Nov 240.04
Oct 240.04
EV/EBITDA
57.51012.51517.5med 11.28Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VATE EV/EBITDA by year
PeriodEV/EBITDA
Sep 266.24
Sep 266.23
Sep 266.26
Aug 266.28
Aug 266.32
Aug 266.33
Aug 266.83
Jul 2611.17
Jul 2611.21
Jul 2611.35
Jul 2611.53
Jul 2612.52
Jun 2613.42
Jun 2613.57
Jun 2612.9
Jun 2613.36
May 2612.6
May 2612.17
May 2611.68
May 2613.16
May 2613.17
Apr 2613.45
Apr 2612.92
Apr 2612.43
Apr 2612.25
Mar 2611.51
Mar 2615.32
Mar 2615.38
Mar 2615.53
Feb 2615.67
Feb 2615.61
Feb 2615.6
Feb 2615.67
Jan 2615.75
Jan 2615.75
Jan 2615.75
Jan 2615.61
Jan 2615.64
Dec 2515.57
Dec 2515.64
Dec 2515.44
Dec 2515.57
Nov 2515.64
Nov 2515.65
Nov 2515.63
Nov 2514.51
Oct 2514.44
Oct 2514.49
Oct 2514.21
Oct 2514.18
Oct 2514.24
Sep 2514.28
Sep 2514.34
Sep 2514.34
Sep 2514.5
Aug 2514.44
Aug 2514.3
Aug 2514.25
Aug 2514.37
Aug 2510.11
Jul 2510.2
Jul 2510.14
Jul 2510.16
Jul 2510.14
Jun 2510.12
Jun 2510.12
Jun 2510.13
Jun 2510.19
May 2510.2
May 2510.29
May 2510.24
May 2510.43
May 2510.25
Apr 2510.23
Apr 2510.08
Apr 2510.16
Apr 2510.08
Mar 259.54
Mar 259.61
Mar 259.49
Mar 259.52
Feb 259.69
Feb 259.95
Feb 2510.25
Feb 2510.12
Jan 2510.08
Jan 259.92
Jan 259.07
Jan 259.05
Jan 259.13
Dec 249.11
Dec 249.09
Dec 249.13
Dec 249.25
Nov 249.22
Nov 249.21
Nov 248.9
Nov 248.97
Nov 248.35
Oct 248.39
Price/Operating Cashflow
02.557.510med 1.56Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
VATE Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 260.52
Sep 260.51
Sep 260.53
Aug 260.54
Aug 260.56
Aug 260.57
Aug 260.87
Jul 260.53
Jul 260.54
Jul 260.58
Jul 260.64
Jul 260.96
Jun 261.25
Jun 261.3
Jun 261.08
Jun 261.23
May 260.99
May 260.85
May 260.69
May 261.07
May 261.07
Apr 261.18
Apr 260.97
Apr 260.78
Apr 260.71
Mar 260.42
Mar 260.61
Mar 260.64
Mar 260.73
Feb 260.81
Feb 260.77
Feb 260.77
Feb 260.81
Jan 260.85
Jan 260.85
Jan 260.85
Jan 260.77
Jan 260.79
Dec 250.75
Dec 250.79
Dec 250.68
Dec 250.75
Nov 250.79
Nov 250.8
Nov 250.79
Nov 251.9
Oct 251.81
Oct 251.88
Oct 251.52
Oct 251.48
Oct 251.56
Sep 251.6
Sep 251.69
Sep 251.69
Sep 251.89
Aug 251.81
Aug 251.63
Aug 251.57
Aug 251.72
Aug 253.39
Jul 253.74
Jul 253.5
Jul 253.57
Jul 253.5
Jun 253.45
Jun 253.43
Jun 253.47
Jun 253.7
May 253.72
May 254.06
May 253.86
May 254.56
May 259.72
Apr 259.53
Apr 258.34
Apr 258.98
Apr 258.31
Mar 253.66
Mar 253.87
Mar 253.5
Mar 253.61
Feb 254.09
Feb 254.85
Feb 255.73
Feb 255.33
Jan 255.21
Jan 254.75
Jan 252.29
Jan 252.24
Jan 252.45
Dec 242.39
Dec 242.36
Dec 242.47
Dec 242.8
Nov 242.72
Nov 242.69
Nov 241.79
Nov 242.01
Nov 240.63
Oct 240.67
Price to Book
0102030med 0.56Jun 20Sep 20Jan 21Apr 21Aug 21Nov 21Mar 22
VATE Price to Book by year
PeriodPrice to Book
Mar 2216.13
Feb 2216.73
Feb 2218.85
Feb 2218.31
Feb 2218.76
Jan 2218.51
Jan 2218.71
Jan 2220.09
Jan 2218.85
Dec 2118.31
Dec 2118.46
Dec 2117.82
Dec 2118.61
Dec 2118.81
Nov 2119.55
Nov 2121.18
Nov 2122.86
Nov 2122.52
Oct 210.58
Oct 210.56
Oct 210.56
Oct 210.56
Oct 210.6
Sep 210.6
Sep 210.54
Sep 210.53
Sep 210.54
Aug 210.55
Aug 210.52
Aug 210.55
Aug 210.57
Jul 210.65
Jul 210.62
Jul 210.64
Jul 210.69
Jul 210.71
Jun 210.75
Jun 210.7
Jun 210.76
Jun 210.76
May 210.71
May 210.7
May 210.71
May 210.66
Apr 210.42
Apr 210.41
Apr 210.38
Apr 210.41
Apr 210.4
Mar 210.39
Mar 210.4
Mar 210.37
Mar 210.38
Feb 210.38
Feb 210.43
Feb 210.42
Feb 210.42
Jan 210.38
Jan 210.4
Jan 210.38
Jan 210.36
Dec 200.35
Dec 200.4
Dec 200.34
Dec 200.4
Dec 200.38
Nov 200.36
Nov 200.26
Nov 200.25
Nov 200.29
Oct 200.27
Oct 200.29
Oct 200.28
Oct 200.31
Oct 200.31
Sep 200.28
Sep 200.31
Sep 200.29
Sep 200.3
Aug 200.33
Aug 200.35
Aug 200.34
Aug 201.67
Jul 201.57
Jul 201.61
Jul 201.66
Jul 201.6
Jul 201.86
Jun 201.89
Jun 202.19
Jun 201.9
Jun 201.87
May 201.53
May 201.6
May 201.43
May 200.28
May 200.24
Apr 200.25
Apr 200.21
Apr 200.2
INNOVATE Corp.
VATE
Stockpicker

Video analysis: VATE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: VATE

INNOVATE Announces Closing of the Sale of a Controlling Interest in its Broadcasting Segment to CONX

globenewswire.com · 2 Sep 2026

INNOVATE Announces Closing of the Sale of a Controlling Interest in its Broadcasting Segment to CONX

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.

VATE Q2 Earnings Improve Y/Y as Infrastructure Revenues Surge

zacks.com · 18 Aug 2026

VATE Q2 Earnings Improve Y/Y as Infrastructure Revenues Surge

INNOVATE swings to a Q2 profit as revenues surge 74.2% y/y, fueled by DBM Global's growth, wider margins and backlog gains, while debt and liquidity remain in focus.

MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology

globenewswire.com · 18 Aug 2026

MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology

NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an equity method investment of INNOVATE, announced that The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, has nominated the MediBeacon® TGFR™ System for the 2026 Prix Galien USA Best Medical Technology.

INNOVATE Agrees to $650 Million Sale of DBM Global to IES Holdings

globenewswire.com · 10 Aug 2026

INNOVATE Agrees to $650 Million Sale of DBM Global to IES Holdings

NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that it has entered into a Transaction Agreement (the “Agreement”) pursuant to which IES Holdings, Inc. (Nasdaq: IESC) (“IES”) will acquire DBM Global, Inc. (“DBMG”) for cash and stock consideration valued at $650 million (the “Transaction”).

IES Holdings to Acquire DBM Global

globenewswire.com · 10 Aug 2026

IES Holdings to Acquire DBM Global

HOUSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- IES Holdings, Inc. (“IES”) (NASDAQ: IESC) today announced that it has entered into a definitive agreement to acquire DBM Global Inc. (“DBM Global”), a vertically integrated structural steel fabrication, erection and industrial services platform, from INNOVATE Corp. (“INNOVATE”) (NYSE: VATE) (the “Transaction”). The consideration for DBM Global, including minority interests, is approximately $650 million, comprised of cash and shares of IES common stock.

INNOVATE Q2 Earnings Call Highlights

marketbeat.com · 9 Aug 2026

INNOVATE Q2 Earnings Call Highlights

INNOVATE NYSE: VATE reported second-quarter 2026 revenue of $421.6 million, up 74.2% from $242 million a year earlier, as its Infrastructure segment delivered record revenue, wider margins and backlog growth. The company posted net income attributable to common and participating preferred stockholders of $10.4 million, or $0.71 per fully diluted share, compared with a net loss of $22 million, or $1.67 per fully diluted share, in the prior-year quarter.

INNOVATE Corp. (VATE) Q2 2026 Earnings Call Prepared Remarks Transcript

seekingalpha.com · 7 Aug 2026

INNOVATE Corp. (VATE) Q2 2026 Earnings Call Prepared Remarks Transcript

INNOVATE Corp. (VATE) Q2 2026 Earnings Call Prepared Remarks Transcript

INNOVATE Corp. to Report Second Quarter 2026 Results on August 6th

globenewswire.com · 3 Aug 2026

INNOVATE Corp. to Report Second Quarter 2026 Results on August 6th

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the second quarter 2026 on Thursday, August 6, 2026, after market close.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.